Anemia in Pregnancy and Risk of Blood Transfusion
ACOG ePoster. Scholz R. Apr 27, 2018; 211528; 11C
Rob Scholz
Rob Scholz
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)
Introduction: A third of women have antepartum anemia, potentially leading to maternal and neonatal morbidity and mortality. Allogenic blood transfusion is often an appropriate treatment. Available evidence suggests antepartum correction may decrease postpartum transfusion volumes. This retrospective cohort study investigated the relationship between anemia at mid-trimester (24-28 weeks or third trimester) and estimated blood loss (EBL) and transfusion at delivery.

Methods: All deliveries between January 2014 and March 2015 at our institution were eligible for inclusion. Exclusion criteria included delivery
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings